Otros idiomas Bausch Health Companies Inc.

Acciones

BHC

CA0717341071

Farmacéuticos

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 12/02/2026			Variación 5 días	Varia. 1 de enero.
5,840 ^USD	-3,95 %		+1,92 %	-15,97 %

27/01	RBC anticipa los resultados del cuarto trimestre de Bausch Health	MT
23/01	TSX Cierra en Nuevo Récord: Novena Marca Histórica de 2026; Rosenberg Explica "Por Qué el Sector de Bienes de Consumo Básico Vuelve a Ser Interesante"	MT

Otros idiomas

27/01	RBC Previews Bausch Health's Fourth-Quarter Results
23/01	TSX Closer: Sets Ninth Record Close of 2026; Rosenberg On 'Why Consumer Staples Look Interesting Again'
23/01	Sector Update: Health Care Stocks Softer Late Afternoon
23/01	Truist Says RED-C Failure "Adds Further Pressure" on the Bausch Health Franchise; BHC Down 10% In Canada
23/01	Sector Update: Health Care Stocks Softer in Afternoon Trading
23/01	Sector Update: Health Care
23/01	Toronto Stocks Nudge Higher With Gains by Miners, Energy Companies
23/01	TSX up 93 Points at Midday With Info Tech, Commodities, The Best Performers
23/01	Bausch Health Shares Fall After Phase 3 Hepatic Encephalopathy Trials Miss Goal
23/01	TSX hits record high as gold nears $5,000 threshold
23/01	Bausch Health Companies Inc. Provides Update on RED-C Phase 3 Clinical Trials
23/01	Bausch Health Down 4% in Pre-market Trade, Says RED-C Phase 3 Trials "Did Not Meet" Primary Endpoint
23/01	Bausch Health's Phase 3 Trials Treating Hepatic Encephalopathy Fail to Meet Primary Endpoint
23/01	Bausch Health Brief: Providing Update on RED-C Phase 3 Clinical Trials
23/01	Bausch Health's brain dysfunction treatment fails late-stage trials
23/01	Bausch Health provides update on RED-C phase 3 clinical trials
13/01	Bausch Health Brief: Co Provides Filing Ahead of Participating in 44th Annual J.P. Morgan Healthcare Conference on Jan. 14, 2026
13/01	Bausch Health Brief: Management Expects to Reaffirm FY25 Guidance at Higher End of Range for Itself Excluding Bausch + Lomb As Provided In October
02/01	Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
29/12	Bausch Health Companies Inc. and 1261229 B.C. Ltd. Completes the Previously announced Offers to Exchange it?s Outstanding 4.875% Senior Secured Notes Due 2028 and 11.00% Senior Secured Notes Due 2028
12/12	Bausch + Lomb Refinancing Outstanding Term B Loans
12/12	Bausch + Lomb Brief: Announcing Refinancing of Outstanding Term B Loans
09/12	Bausch Health Companies Inc. Announces Early Results of Senior Secured Notes Exchange Offers Announced
01/12	Sector Update: Health Care Stocks Decline Late Afternoon
01/12	Sector Update: Health Care Stocks Decline Monday Afternoon

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Artículos de MarketScreener Estrategias MarketScreener Ideas de trading

Otros idiomas Bausch Health Companies Inc.

Acciones

BHC

CA0717341071

Farmacéuticos

Otros idiomas

Filtros